IPO7 anticorps (N-Term)
Aperçu rapide pour IPO7 anticorps (N-Term) (ABIN2290504)
Antigène
Voir toutes IPO7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 149-179, N-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- IPO7, NT (IPO7, RANBP7, Importin-7, Ran-binding protein 7)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- IPO7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 149-179 amino acids from the N-terminal region of human IPO7.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- IPO7 (Importin 7 (IPO7))
-
Autre désignation
- IPO7
-
NCBI Accession
- NP_006382
-
UniProt
- O95373
-
Pathways
- Protein targeting to Nucleus
Antigène
-